Clin Nutr 41(4):948957
Yuan H, Perry CN, Huang C, Iwai-Kanai E, Carreira RS, Glembotski CC, and Gottlieb RA
The correct statement: at their respective maximum doses, Zepbound produces more weight loss than Wegovy in head-to-head trials
Both hormones help stimulate insulin secretion, but GLP-1 also inhibits glucagon release during hyperglycemia, slows gastric emptying and promotes satiety
Do not rub the injection site, as this can alter absorption and cause irritation
HCPCS J3380 Biologics (IL-23 inhibitor): Risankizumab (Skyrizi, J7999) newer biologic for moderate-to-severe CD